Cargando…

Can GPR4 Be a Potential Therapeutic Target for COVID-19?

Coronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in late 2019 and has since rapidly become a global pandemic. SARS-CoV-2 infection causes damages to the lung and other organs. The clinical manifestations of COVID-19 range widely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Li V., Oppelt, Karen A., Thomassen, Mary Jane, Marie, Mona A., Nik Akhtar, Shayan, McCallen, Justin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859652/ https://www.ncbi.nlm.nih.gov/pubmed/33553219 http://dx.doi.org/10.3389/fmed.2020.626796

Ejemplares similares

The Proton-Sensing GPR4 Receptor Regulates Paracellular Gap Formation and Permeability of Vascular Endothelial Cells
por: Krewson, Elizabeth A., et al.
Publicado: (2020)

The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015)

GPR35 as a Novel Therapeutic Target
por: MacKenzie, A. E., et al.
Publicado: (2011)

Evaluating the impact of hydroxychloroquine on mouse lymphocyte proliferation and cytokine production in vivo and in vitro
por: Wabitsch, Simon, et al.
Publicado: (2021)

The Spatial Distribution of the Japanese Beetle, Popillia japonica, in Soybean Fields
por: Sara, Stacey A., et al.
Publicado: (2013)

Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models
por: Wabitsch, Simon, et al.
Publicado: (2020)

Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets
por: Ulven, Trond
Publicado: (2012)

Case Report: Peripheral blood T cells and inflammatory molecules in lung cancer patients with immune checkpoint inhibitor-induced thyroid dysfunction: Case studies and literature review
por: Marie, Mona A., et al.
Publicado: (2022)

Comparison of three commercial RT-PCR systems for the detection of respiratory viruses
por: Butt, S.A., et al.
Publicado: (2014)

GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice
por: Zhao, Jie, et al.
Publicado: (2016)

Platelet–Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma
por: Shah, Sajeel A., et al.
Publicado: (2017)

Sirtuins as Potential Therapeutic Targets for Hepatitis B Virus Infection
por: Kong, Fanyun, et al.
Publicado: (2021)

GPR35 acts a dual role and therapeutic target in inflammation
por: Wu, Yetian, et al.
Publicado: (2023)

Potential Metabolic and Behavioural Roles of the Putative Endo- cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
por: Ramírez-Orozco, Ricardo E., et al.
Publicado: (2019)

Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
por: Pechlivani, Nikoletta, et al.
Publicado: (2018)

AMPK: Potential Therapeutic Target for Vascular Calcification
por: Lu, Yi, et al.
Publicado: (2021)

Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
por: Burant, Charles F.
Publicado: (2013)

CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
por: Zhou, Juan, et al.
Publicado: (2016)

Novel Insight of CircRNAs in Cervical Cancer: Potential Biomarkers and Therapeutic Target
por: Wu, Maomao, et al.
Publicado: (2022)

Exploring potential biomarkers and therapeutic targets of long COVID-associated inflammatory cardiomyopathy
por: Qi, Peng, et al.
Publicado: (2023)

Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery
por: Mishra, Abhinav P., et al.
Publicado: (2018)

Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
por: Ye, Wen-Chu, et al.
Publicado: (2021)

PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
por: Dong, Xiaocheng Charlie
Publicado: (2019)

Editorial: Aldehyde dehydrogenase in clinical settings: Potential biomarker and therapeutic target in solid tumors
por: Aramini, Beatrice, et al.
Publicado: (2023)

A Novel Non-invasive Model Based on GPR for the Prediction of Liver Fibrosis in Patients With Chronic Hepatitis B
por: Ding, Rongrong, et al.
Publicado: (2021)

GPR68: An Emerging Drug Target in Cancer
por: Wiley, Shu Z., et al.
Publicado: (2019)

Therapeutic Opportunities and Challenges in Targeting the Orphan G Protein-Coupled Receptor GPR35
por: Quon, Tezz, et al.
Publicado: (2020)

Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer
por: Sáez-Martínez, Prudencio, et al.
Publicado: (2020)

Electrocardiographic Changes and Arrhythmias in Hospitalized Patients With COVID-19
por: Moey, Melissa Y.Y., et al.
Publicado: (2020)

Comprehensive Analysis Identifies Potential Ferroptosis-Associated mRNA Therapeutic Targets in Ovarian Cancer
por: Zhang, Jiyan, et al.
Publicado: (2021)

Caveolin-1 in vascular health and glaucoma: A critical vascular regulator and potential therapeutic target
por: Loo, Jing Hong, et al.
Publicado: (2023)

GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass
por: Eriksson, Olof
Publicado: (2019)

FFA4/GPR120: Pharmacology and Therapeutic Opportunities
por: Milligan, Graeme, et al.
Publicado: (2017)

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
por: Soares, Cleverson T., et al.
Publicado: (2018)

Serum amyloid A—A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19
por: Almusalami, Eman M., et al.
Publicado: (2023)

Genetic variants of the unsaturated fatty acid receptor GPR120 relating to obesity in dogs
por: MIYABE, Masahiro, et al.
Publicado: (2015)

Editorial: Organ Fibrosis: Pathogenesis, Biomarkers and Therapeutic Targets
por: Mutsaers, Henricus A. M., et al.
Publicado: (2021)

Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma
por: ADACHI, Mami, et al.
Publicado: (2015)

Immune-related potential biomarkers and therapeutic targets in coronary artery disease
por: Liu, Chaosheng, et al.
Publicado: (2023)

New Therapeutic Targets in Autoimmune Cholangiopathies
por: Gerussi, Alessio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r8o2dtrrb0t87tmhs3ejco3vcl